Hefei Lifeon Pharmaceutical Co., Ltd.
003020.SZ
Price:
$27.4
Market Cap:
$5.21B
Hefei Lifeon Pharmaceutical Co., Ltd. engages research, development, production, and sales of pharmaceutical preparations and an active ingredient (APIs). It offers APIs, such as succimer, urea, paeonol, felodipine, doxazosin mesylate, zofenopril calcium, troxerutin, and sodium 2,3-dimercapto-1-propanesulfonate; medicinal preparations comprising felodipine sustained release tablets, doxazosin mesylate extended-release tablets, melbinum glipizide tablet, yiqihewei capsule, kunning granule, armillariella oral solution, paeonol ointment, urea and vitamin e cream, Kecuo Yintong gel, and Compound Golden Larch bark gel; and plant extracts, including clove oil, evening primrose oil, herba clinopodi...[Read more]
Industry
Biotechnology
IPO Date
2020-12-15
Stock Exchange
SHZ
Ticker
003020.SZ
PE Ratio
[32.24]
ROE
[9.18%]
Current Ratio
[2.21]
Dividend Yield
[1.82%]
Enterprise Value
[4.87B]
Dividend History
The ROE as of December 2025 (TTM) for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) is 9.18%
According to Hefei Lifeon Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 9.18%. This represents a change of 299.43% compared to the average of 2.30% of the last 4 quarters.
Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) Historical ROE (quarterly & annually)
How has 003020.SZ ROE performed in the past?
The mean historical ROE of Hefei Lifeon Pharmaceutical Co., Ltd. over the last ten years is 16.59%. The current 9.18% ROE has changed -44.65% with respect to the historical average. Over the past ten years (40 quarters), 003020.SZ's ROE was at its highest in in the June 2020 quarter at 5.89%. The ROE was at its lowest in in the September 2025 quarter at 1.71%.
Average
16.59%
Median
15.98%
Minimum
9.24%
Maximum
24.56%
Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of Hefei Lifeon Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 14.77%
Maximum Annual ROE = 24.56%
Minimum Annual Increase = -35.42%
Minimum Annual ROE = 9.24%
| Year | ROE | Change |
|---|---|---|
| 2024 | 9.24% | -31.28% |
| 2023 | 13.45% | -4.87% |
| 2022 | 14.14% | 7.02% |
| 2021 | 13.21% | 14.77% |
| 2020 | 11.51% | -35.42% |
| 2019 | 17.82% | -1.69% |
| 2018 | 18.13% | -14.65% |
| 2017 | 21.24% | -6.16% |
| 2016 | 22.63% | -7.86% |
| 2014 | 24.56% | -6.76% |
Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) Average ROE
How has 003020.SZ ROE performed in the past?
The current ROE of Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.28%
5-year avg
12.31%
10-year avg
16.59%
Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) ROE vs. Peers
How is 003020.SZ’s ROE compared to its peers?
Hefei Lifeon Pharmaceutical Co., Ltd.’s ROE is less than Assure Tech (Hangzhou) Co., Ltd. (2.33%), less than GuiZhou SanLi Pharmaceutical Co.,Ltd (10.61%), less than Beijing Kawin Technology Share-Holding Co., Ltd. (7.43%), less than Novogene Co., Ltd. (6.88%), less than Pulike Biological Engineering, Inc. (5.48%), less than Shanghai Hile Bio-Technology Co., Ltd. (10.96%), greater than Jiangxi Fushine Pharmaceutical Co., Ltd. (-12.56%), less than Beijing Scitop Bio-tech Co., Ltd. (5.51%), less than Fuan Pharmaceutical (Group) Co., Ltd. (3.26%), greater than Berry Genomics Co.,Ltd (-15.45%),
| Company | ROE | Market cap |
|---|---|---|
| 2.33% | $4.98B | |
| 10.61% | $4.89B | |
| 7.43% | $4.27B | |
| 6.88% | $5.54B | |
| 5.48% | $4.47B | |
| 10.96% | $4.71B | |
| -12.56% | $7.92B | |
| 5.51% | $4.58B | |
| 3.26% | $5.50B | |
| -15.45% | $4.10B |
Build a custom stock screener for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hefei Lifeon Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hefei Lifeon Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Hefei Lifeon Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)?
What is the highest ROE for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)?
What is the 3-year average ROE for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)?
What is the 5-year average ROE for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)?
How does the current ROE for Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) compare to its historical average?